Imunon, Inc. (IMNN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Imunon, Inc. on November 27, 2024, regarding an event dated November 26, 2024. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "IMNN".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes and Listing Status
On November 26, 2024, the Company received a deficiency notice from Nasdaq stating that the closing bid price of its common stock had been below the minimum $1.00 per share requirement for 30 consecutive business days. This triggers a potential delisting process under Nasdaq Listing Rule 5550(a)(2).
- Current Status: The stock continues to trade on the Nasdaq Capital Market with no immediate effect on listing.
- Compliance Period: The Company has an initial 180 calendar days (until May 27, 2025) to regain compliance.
- Requirement: The closing bid price must be $1.00 or more for at least 10 consecutive business days before the deadline.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the stock price and consider available options to regain compliance. The filing includes standard forward-looking statement disclaimers, noting that there is no assurance the Company will meet the bid price requirement or that Nasdaq will grant any relief from delisting if the deficiency is not cured.
If the Company fails to regain compliance by May 27, 2025, it may be eligible for an additional 180-day period, provided it meets the market value of publicly held shares requirement and other initial listing standards. Failure to cure the deficiency could result in delisting.
Key Facts for Investor Verification
- Verify the current closing bid price of IMNN to assess proximity to the $1.00 threshold.
- Monitor the stock price for 10 consecutive business days to determine if the initial compliance period is met.
- Review the Company's market value of publicly held shares to assess eligibility for a potential second compliance period.
- Check for any future announcements regarding reverse stock splits or other corporate actions intended to raise the share price.